These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34466446)

  • 1. Comparative Bioinformatics Characteristic of Bladder Cancer Stage 2 from Stage 4 Expression Profile: A Network-Based Study.
    Zamanian Azodi M; Rezaei Tavirani M; Rostami-Nejad M; Rezaei-Tavirani M
    Galen Med J; 2018; 7():e1279. PubMed ID: 34466446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
    Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
    Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
    Durrani IA; Bhatti A; John P
    PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis.
    Cheng H; Liu Y; Chen G
    BMC Urol; 2023 Aug; 23(1):135. PubMed ID: 37563710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying possible hub genes and biological mechanisms shared between bladder cancer and inflammatory bowel disease using machine learning and integrated bioinformatics.
    Liu J; Wu P; Lai S; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16885-16904. PubMed ID: 37740761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of key biomarkers for bladder cancer.
    Liu W; Xu Y; Bai S; Liao L
    Biomed Rep; 2023 Feb; 18(2):14. PubMed ID: 36643693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis.
    Hu W; Fang T; Chen X
    Front Genet; 2022; 13():914384. PubMed ID: 35719390
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated analysis of key microRNAs, regulatory pathways and clinical relevance in bladder cancer.
    Li D; Hao X; Song Y
    Onco Targets Ther; 2018; 11():3075-3085. PubMed ID: 29872319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
    Xing X; Xia Q; Gong B; Shen Z; Zhang Y
    Front Genet; 2022; 13():855557. PubMed ID: 35368701
    [No Abstract]   [Full Text] [Related]  

  • 14. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
    Sun Y; Cai D; Hu W; Fang T
    Front Genet; 2022; 13():950136. PubMed ID: 36118873
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
    Xie R; Li B; Jia L; Li Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics-Based Study to Investigate Potential Differentially Expressed Genes and miRNAs in Pediatric Sepsis.
    Xie K; Kong S; Li F; Zhang Y; Wang J; Zhao W
    Med Sci Monit; 2020 Jun; 26():e923881. PubMed ID: 32575108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed genes and biological pathways in bladder cancer.
    Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
    Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.